Voorspellende waarde van soluble mesothelin-related peptide, CEA, Cyfra 21-1 and CA 125 bij patiënten met pleuravocht.
Not yet recruiting
- Conditions
- pleural effusion, tumour markers, mesothelin. pleuravocht, tumormarkers, mesotheline
- Registration Number
- NL-OMON20116
- Lead Sponsor
- Maatschap longziekten MST EnschedeMaatschap longziekten ZGT Almelo
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion Criteria
1. Pleural fluid;
2. Age over 18 years;
Exclusion Criteria
1. Known cause of the pleural fluid;
2. Clinical and/or radiological suspicion for pleural empyema;
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To test the diagnostic capacity for malignancy in pleural fluid of the tumour markers SMRP, CEA, Cyfra 21-1 and Ca 125 by patients presenting with pleural fluid without any known or suspected cause.
- Secondary Outcome Measures
Name Time Method The prognostic capacity of the same markers in malignant pleural disease.